Management of placenta accreta

Acta Obstetricia et Gynecologica Scandinavica

Volumn 92, Issue 10, 2013, Pages 1125-1134

  Sentilhes, Loïc ^a   Goffinet, François ^b   Kayem, Gilles ^c  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b Institut Cochin   (France)

^c HÔPITAL LOUIS MOURIER   (France)

Author keywords

Abnormally invasive placenta; antenatal diagnosis; cesarean hysterectomy; conservative treatment; management; placenta accreta or percreta

Indexed keywords

METHOTREXATE; ABORTIVE AGENT;

ABDOMINAL INFECTION; ACUTE KIDNEY FAILURE; APLASIA; ARTIFICIAL EMBOLISM; BALLOON CATHETER; BLADDER; BLADDER METASTASIS; BLEEDING; BLOOD CLOTTING DISORDER; CESAREAN SECTION; CONSERVATIVE TREATMENT; CYSTOTOMY; CYSTOVAGINAL FISTULA; DEATH; DELIVERY; DIGESTIVE SYSTEM DISEASE; ERYTHROCYTE; FOLLOW UP; HUMAN; HYSTERECTOMY; MATERNAL MORBIDITY; MONITORING; NEPHROTOXICITY; NEUTROPENIA; PERITONITIS; PLACENTA; PLACENTA ACCRETA; PLACENTAL DELIVERY; PREGNANCY; PRIORITY JOURNAL; REOPERATION; REVIEW; RISK; SEPTIC SHOCK; THROMBOEMBOLISM; URETER INJURY; URETER STENT; VAGINAL DELIVERY; FEMALE; FERTILITY PRESERVATION; HEMOSTASIS; MULTIMODALITY CANCER THERAPY; PRENATAL DIAGNOSIS;

ABORTIFACIENT AGENTS, NONSTEROIDAL; CESAREAN SECTION; COMBINED MODALITY THERAPY; FEMALE; FERTILITY PRESERVATION; HEMOSTATIC TECHNIQUES; HUMANS; HYSTERECTOMY; METHOTREXATE; PLACENTA ACCRETA; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84884912205     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12222     Document Type: Review

References (42)

1. Tseng JJ, Chou MM, Hsiehb YT, Wene MC, Hob ES, Hsuf SL,. Differential expression of vascular endothelial growth factor, placenta growth factor and their receptors in placentae from pregnancies complicated by placenta accreta. Placenta. 2006; 27: 70-8. (Pubitemid 41662882)
2. Oyelese Y, Smulian JC,. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006; 107: 927-41.
3. Eller AG, Porter TF, Soisson P, Silver RM,. Optimal management strategies for placenta accreta. BJOG. 2009; 116: 648-54.
4. Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz C, Kelly TF, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010; 115: 65-9.
5. O'Brien JM, Barton JR, Donaldson ES,. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996; 175: 1632-7.
6. Daskalakis G, Anastasakis E, Papantoniou N, Mesogitis S, Theodora M, Antsaklis A,. Emergency obstetric hysterectomy. Acta Obstet Gynecol Scand. 2007; 86: 223-7.
7. Sentilhes L, Trichot C, Resch B, Sergent F, Roman H, Marpeau L, et al. Fertility and pregnancy outcomes following uterine devascularization for severe postpartum haemorrhage. Hum Reprod. 2008; 23: 1087-92. (Pubitemid 351757317)
8. Sentilhes L, Gromez A, Clavier E, Resch B, Verspyck E, Marpeau L,. Predictors of failed pelvic arterial embolization for severe postpartum hemorrhage. Obstet Gynecol. 2009; 113: 992-9.
9. Kayem G, Deneux-Tharaux C, Sentilhes L, PACCRETA group. PACCRETA: clinical situations at high risk of placenta ACCRETA/percreta: impact of diagnostic methods and management on maternal morbidity. Acta Obstet Gynecol Scand. 2013; 92: 476-82.
10. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V,. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand. 2011; 90: 1140-6.
11. Eller AG, Bennett MA, Sharshiner M, Masheter C, Soisson AP, Dodson M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol. 2011; 117: 311-17.
12. Robinson BK, Grobman WA,. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 2010; 116: 835-42.
13. Esakoff TF, Handler SJ, Granados JM, Caughey AB,. PAMUS: placenta accreta management across the United States. J Matern Fetal Neonatal Med. 2012; 25: 761-5.
14. Jolley JA, Nageotte MP, Wing DA, Shrivastava VK,. Management of placenta accreta: a survey of Maternal-Fetal Medicine practitioners. J Matern Fetal Neonatal Med. 2012; 25: 756-60.
15. Kayem G, Davy C, Goffinet F, Thomas C, Clement D, Cabrol D,. Conservative versus extirpative management in cases of placenta accreta. Obstet Gynecol. 2004; 104: 531-6. (Pubitemid 40458840)
16. Bretelle F, Courbiere B, Mazouni C, Agostini A, Cravello L, Boubli L, et al. Management of placenta accreta: morbidity and outcome. Eur J Obstet Gynecol Reprod Biol. 2007; 133: 34-9. (Pubitemid 46970802)
17. Sentilhes L, Kayem G, Ambroselli C, Provansal M, Fernandez H, Perrotin F, et al. Fertility and pregnancy outcomes following conservative treatment for placenta accreta. Hum Reprod. 2010; 25: 2803-10.
18. American College of Obstetricians and Gynecologists. Postpartum hemorrhage. ACOG Educational Bulletin 243. Washington, DC: ACOG, 1998.
19. Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA,. Placenta accreta. Am J Obstet Gynecol. 2010; 203: 430-9.
20. Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD,. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol. 2008; 199: 36. e1-36. e5.
21. Angstmann T, Gard G, Harrington T, Ward E, Thomson A, Giles W,. Surgical management of placenta accreta: a cohort series and suggested approach. Am J Obstet Gynecol. 2010; 202: 38. e1-9.
22. Hoffman MS, Karlnoski RA, Mangar D, Whiteman VE, Zweibel BR, Lockhart JL, et al. Morbidity associated with non emergent hysterectomy for placenta accreta. Am J Obstet Gynecol. 2010; 202: 628. e1-5.
23. Kayem G, Sentilhes L, Deneux-Tharaux C,. Management of placenta accreta. BJOG. 2009; 116: 1536-7.
24. Sentilhes L, Descamps P, Goffinet F,. Arteriovenous malformation following conservative treatment of placenta percreta with uterine artery embolization but no adjunctive therapy. Am J Obstet Gynecol. 2011; 205: e13.
25. Shrivastava V, Nageotte M, Major C, Haydon M, Wing D,. Case-control comparison of cesarean hysterectomy with and without prophylactic placement of intravascular balloon catheters for placenta accreta. Am J Obstet Gynecol. 2007; 197: 402. e1-5.
26. Levine AB, Kuhlman K, Bonn J,. Placenta accreta: comparison of cases managed with and without pelvic artery balloon catheters. J Matern Fetal Med. 1999; 8: 173-6. (Pubitemid 29297282)
27. Bodner LJ, Nosher JL, Gribbin C, Siegel RL, Beale S, Scorza W,. Balloon-assisted occlusion of the internal iliac arteries in patients with placenta accreta/percreta. Cardiovasc Intervent Radiol. 2006; 29: 354-61.
28. Dilauro MD, Dason S, Athreya S,. Prophylactic balloon occlusion of internal iliac arteries in women with placenta accreta: literature review and analysis. Clin Radiol. 2012; 67: 515-20.
29. Royal College of Obstetricians and Gynaecologists. Green-top Guideline No. 27: Placenta praevia, placenta praevia accrete and vasa praevia: diagnosis and management. London: RCOG, 2011.
30. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010; 115: 526-34.
31. Alanis M, Hurst BS, Marshburn PB, Matthews ML,. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril. 2006; 86: 1514. e3-7.
32. Mussalli GM, Shah J, Berck DJ, Elimian A, Tejani N, Manning FA,. Placenta accreta and methotrexate therapy: three case reports. J Perinatol. 2000; 20: 331-4.
33. Timmermans S, van Hof AC, Duvekot JJ,. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv. 2007; 62: 529-39. (Pubitemid 47203383)
34. Isaacs JD Jr, McGehee RP, Cowan BD,. Life-threatening neutropenia following methotrexate treatment of ectopic pregnancy: a report of two cases. Obstet Gynecol. 1996; 88: 694-6. (Pubitemid 26331181)
35. Bouvier A, Sentilhes L, Thouveny F, Bouet PE, Gillard P, Willoteaux S, et al. Planned caesarean in the interventional radiology cath lab to enable immediate uterine artery embolization for the conservative treatment of placenta accreta. Clin Radiol. 2012; 67: 1089-94.
36. Palacios-Jaraquemada JM, Pesaresi M, Nassif JC, Hermosid S,. Anterior placenta percreta: surgical approach, hemostasis and uterine repair. Acta Obstet Gynecol Scand. 2004; 83: 738-44. (Pubitemid 39062148)
37. Palacios-Jaraquemada JM,. Diagnosis and management of placenta accreta. Best Pract Res Clin Obstet Gynecol. 2008; 22: 1133-48.
38. Palacios-Jaraquemada JM,. Placental adhesive disorders. Berlin/Boston: Walter de Gruyter GmbH and Co. KG, 2012.
39. Kayem G, Deis S, Estrade S, Haddad B,. Conservative management of a near-term cervico-isthmic pregnancy, followed by a successful subsequent pregnancy: a case report. Fertil Steril. 1826; 2008 (89): e13-15.
40. Amsalem H, Kingdom JC, Farine D, Allen L, Yinon Y, D'Souza DL, et al. Planned caesarean hysterectomy versus "conserving" caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 2011; 33: 1005-10.
41. Washecka R, Behling A,. Urologic complications of placenta percreta invading the urinary bladder: a case report and review of the literature. Hawaii Med J. 2002; 61: 66-69.
42. Hayes E, Ayida G, Crocker A,. The morbidly adherent placenta: diagnosis and management options. Curr Opin Obstet Gynecol. 2011; 23: 448-53.